PTPRC and neoplasm: We appreciated a significant increase in systemic MDSCs (as a fraction CD45 splenocytes) in mice bearing large tumors as compared to tumor-naïve mice; 4% to 18.6%; p < 0.01 (Figure 5A-top panel).